References
- Hua Q, Fan L, Li J. 2019. 2019 Chinese guideline for the management of hypertension in the elderly. J Geriatric Cardiol. 16(2):67–99. doi:https://doi.org/10.11909/j.1671-5411.2019.02.001.
- Bardin T, Richette P. 2017. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 15(1):123. doi:https://doi.org/10.1186/s12916-017-0890-9.
- Zoppini G, Targher G, Negri C, Zoppini G, Targher G, Negri C, Stoico V, Perrone F, Muggeo M, Bonora E. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care. 2009;32(9):1716–20. doi:https://doi.org/10.2337/dc09-0625
- Feig DIKD, Johnson RJ. 2009. Uric acid and cardiovascular risk. N Engl J Med. 360(5):1811–21. doi:https://doi.org/10.1056/NEJMc082360.
- Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, Lanaspa MA, Nakagawa T, Johnson RJ. Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur J Intern Med. 2016;29:3–8
- Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga F. 2018. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 17(1):122. doi:https://doi.org/10.1186/s12933-018-0762-4.
- Krishnan E, Pandya B, Chung L, Hariri A, Dabbous O. 2012. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol. 176(2):108–16. doi:https://doi.org/10.1093/aje/kws002.
- Forman JPCH, Curhan GC, Curhan GC. 2009. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med. 169(2):155–62. doi:https://doi.org/10.1001/archinternmed.2008.521.
- Guerrero-Romero F, Villalobos-Molina R, Jiménez-Flores J, Simental-Mendia LE, Méndez-Cruz R, Murguía-Romero M, Rodríguez-Morán M. Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults. Arch Med Res. 2016;47(5):382–87. doi:https://doi.org/10.1016/j.arcmed.2016.08.012
- Won KB, Park EJ, Han D, Lee JH, Choi S-Y, Chun EJ, Park SH, Han H-W, Sung J, Jung HO, et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc Diabetol. 2020 Mar 16;19(1):34. doi:https://doi.org/10.1186/s12933-020-01008-5.
- Park G-M, Cho Y-R, Won K-B, Yang YJ, Park S, Ann SH, Kim Y-G, Park EJ, Kim S-J, Lee S-G, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020 Jan 14;19(1):7. doi:https://doi.org/10.1186/s12944-020-1187-0.
- Wang Y, Yang W, Jiang X. Association between triglyceride-glucose index and hypertension: a meta-analysis. Front Cardiovasc Med. 2021;8:644035. doi:https://doi.org/10.3389/fcvm.2021.644035.
- Diseases M-DETFoHaIR. Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases. Zhonghua Nei Ke Za Zhi. 2017;56(3):235–48. doi:https://doi.org/10.3760/cma.j.0578-1426.2017.03.021.
- Minh H, Tien H, Sinh C, Thang DC, Chen C-H, Tay JC, Siddique S, Wang T-D, Sogunuru GP, Chia Y-C, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J clin hypertens (Greenwich, Conn). 2021;23(3):529–37. doi:https://doi.org/10.1111/jch.14155.
- Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, Álvarez-Villalobos NA, González-González JG. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol. 2020;2020(4678526):1–7. doi:https://doi.org/10.1155/2020/4678526
- Zhu B, Wang J, Chen K, Yan W, Wang A, Wang W, Gao Z, Tang X, Yan L, Wan Q, et al. A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals: a cross-sectional survey from the reaction study. Cardiovasc Diabetol. 2020 Jul 14;19(1):112. doi:https://doi.org/10.1186/s12933-020-01077-6.
- Abreu E, Fonseca M, Santos A. Association between hyperuricemia and insulin resistance. Acta Med Port. 24\(Suppl 2):565–74
- Nakamura K, Sakurai M, Miura K, Morikawa Y, Nagasawa S-Y, Ishizaki M, Kido T, Naruse Y, Nakashima M, Nogawa K, et al. HOMA-IR and the risk of hyperuricemia: a prospective study in non-diabetic Japanese men. Diabetes Res Clin Pract. 2014 Oct;106(1):154–60. doi:https://doi.org/10.1016/j.diabres.2014.07.006.
- Liu X, Xu X, Zhu J, Zhao D. 2019. Association between three non-insulin-based indexes of insulin resistance and hyperuricemia. Clin Rheumatol. 38(11):3227–33. doi:https://doi.org/10.1007/s10067-019-04671-6.
- Ter Maaten J, Voorburg A, Heine R, Ter Wee P, Donker A, Gans R. 1997. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (London, England: 1979). 92(1):51–58. doi:https://doi.org/10.1042/cs0920051.
- Muscelli E, Natali A, Bianchi S, et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens. 1996;9(8):746–52. doi:https://doi.org/10.1016/0895-7061(96)00098-2.
- Lanaspa M, Sanchez-Lozada L, Choi Y, Cicerchi C, Kanbay M, Roncal-Jimenez CA, Ishimoto T, Li N, Marek G, Duranay M, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287(48):40732–44. doi:https://doi.org/10.1074/jbc.M112.399899.
- Sánchez-Lozada L, Lanaspa M, Cristóbal-García M, García-Arroyo F, Soto V, Cruz-Robles D, Nakagawa T, Yu MA, Kang D-H, Johnson RJ, et al. Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations. Nephron Exp Nephrol. 2012;121(3–4):e71–8. doi:https://doi.org/10.1159/000345509.
- Horita S, Seki G, Yamada H, Suzuki M, Koike K, Fujita T. 2011. Insulin resistance, obesity, hypertension, and renal sodium transport. Int J Hypertens. 2011(391762):1–8. doi:https://doi.org/10.4061/2011/391762.
- Hayden M, Tyagi S. 2004. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab. 1(1):10. doi:https://doi.org/10.1186/1743-7075-1-10.
- Kanellis J, Kang D. 2005. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 25(1):39–42. doi:https://doi.org/10.1016/j.semnephrol.2004.09.007.
- Wang R, Bai Z, Zhang D, Zhang R, Yang J, Yin C, Huang W, Huang P, Wang Y, Liu N, et al.Mediating effects of insulin resistance on the development of hypertension associated with elevated serum uric acid: a prospective cohort study. J Hum Hypertens. 2021;1-7. doi:https://doi.org/10.1038/s41371-021-00562-z.
- Osgood K, Krakoff J, Thearle M. 2013. Serum uric acid predicts both current and future components of the metabolic syndrome. Metab Syndr Relat Disord. 11(3):157–62. doi:https://doi.org/10.1089/met.2012.0151.
- Zhu MQ, Li GQ, MY. Correlation between simple insulin resistance index and hyperuricemia in normal body mass population. Chin J Clin. 2020;14(10):808–12. doi:https://doi.org/10.3877/cma.j.1674-0785.2020.10.011.